Multiple detection method for 17 tick-borne pathogens
Through the design of NovaHT multi-fluorescent bioanalysis system and primer probe composition, the multiple detection problems of tick-borne pathogen detection in the prior art were solved, and efficient and low-cost multiple detection of 17 tick-borne pathogens were achieved, thus improving detection Efficiency and accuracy.
Patent Information
- Application Number
- CN202411310211.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-19
- Publication Date
- 2024-11-08
AI Technical Summary
The existing tick-borne pathogen detection methods have problems such as single detection objects, low sensitivity, high operational difficulty, excessive reliance on subjective judgments and high detection costs, and cannot meet the multiple detection needs of large-scale suspected tick-borne pathogen infections.
Using NovaHT multi-fluorescent bioanalysis system, 17 tick-borne pathogens were tested by designing primer and probe compositions, combined with two-wheel PCR amplification and flow lattice detection, using biotin-avidin and fluorescence Double labeling of microspheres, optimize primer and probe sequences, degenerate base design, and achieve high sensitivity and high accuracy detection of multiple pathogens.
Multiple nucleic acid detection of 17 tick-borne pathogens has been realized, which saves sample collection and detection time, reduces detection costs, improves detection efficiency, has good application prospects, and realizes the digitization of detection results through automated result output and reliability.
Smart Images

Figure BDA0005050424010000041 
Figure BDA0005050424010000052 
Figure BDA0005050424010000053
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biological products, in particular to a multiplex detection method for 17 tick-borne pathogens, and in particular uses a NovaHT multiplex fluorescence bioanalysis system belonging to a liquid phase chip. Background Art
[0002] Ticks are blood-sucking parasites that are widely distributed around the world. They are the second largest vector of infectious diseases after mosquitoes. They carry a variety of pathogens including viruses, rickettsia, bacteria, etc. They can infect and parasitize birds, mammals and other organisms and spread a variety of zoonotic infectious diseases, posing a huge threat to human health and animal husbandry. Establishing nucleic acid detection technology for high-risk tick-borne pathogens is crucial for the prevention and control of tick-borne diseases and clinical diagnosis. However, the existing detection methods for tick-borne pathogens are relatively limited, with limitations such as single detection objects, low sensitivity, high difficulty in operation, and excessive reliance on subjective judgment for results.
[0003] The present invention screens the mainstream tick-borne pathogens that are currently prevalent and seriously harmful at home and abroad as detection targets. Among them, tick-borne viruses include severe fever with thrombocytopenia syndrome bunyavirus (SFTSV), tick-borne encephalitis virus (TBEV, also known as forest encephalitis virus), Hantaan virus (HTNV), Seoul virus (Seoul virus), Xinjiang hemorrhagic fever virus (also known as Crimean-Congo hemorrhagic fever virus, Crimean-Congo Hemorrhagic Fever Virus, CCHFV). Spirochete is a prokaryotic single-cell organism that is biologically between bacteria and protozoa. The detection targets of the present invention mainly include Borrelia recurrentis, Borrelia burgdorferi, and Leptospira, which are transmitted by ticks. Rickettsia is a kind of prokaryotic organism between bacteria and viruses, and close to bacteria. There are many kinds of Rickettsia in my country, including scrub typhus, Q fever, epidemic typhus and more than 20 kinds. The present invention focuses on Anaplasma phagocytophilum, Rickettsia, Rickettsia prowazekii, Rickettsia moseri, Orientiatsutsugamushi, Coxiella burnetii, and Candidatus Ehrlichia erytraense according to the epidemiological survey data. The detection target pathogens also include Bartonella belonging to Gram-negative bacteria and Babesia microti, a parasite belonging to the phylum Protozoa.
[0004] Liquid Array or Suspension Array is a technology that uses microspheres or other suspended carriers to detect in a liquid environment. It combines the advantages of traditional chip technology and modern biochemical analysis methods, and can perform high-throughput detection of biological macromolecules such as proteins and nucleic acids. It is a new type of high-throughput nucleic acid detection platform, mainly including flow fluorescence detection technology (such as Luminex platform) and CCD imaging detection technology (such as BioCode 2500 system), for example, the Luminex platform labels different probes with different fluorescent microspheres, and the probes further specifically bind to the microspheres and nucleic acid sequences. Multiple target detection reactions can be performed in one reaction well, and the binding products will generate light signals under laser excitation of a specific wavelength, thereby realizing multiple detections of nucleic acids. Although it has the advantages of high throughput, flexibility, accuracy, and good repeatability, the traditional liquid chip detection platform has the problems of time-consuming detection methods, cumbersome steps, lack of unified standardized specifications and operating guidelines, resulting in low mutual recognition and comparability of detection results, and the need to rely on high-precision instruments and professional detection systems, resulting in high detection costs. In addition, the development cycle of the traditional liquid chip detection platform is long, the development is difficult, and the development cost is high. Therefore, it is urgent to establish a rapid, high-throughput, standardized, mutually recognized, and low-cost detection method for accurate detection of multiple pathogens, so as to meet the needs of multiple detection of large-scale clinical samples suspected of tick-borne pathogen infection. Summary of the invention
[0005] The object of the present invention is to at least partially overcome the deficiencies of the prior art and to provide a multiplex detection method for 17 tick-borne pathogens.
[0006] To achieve the above objectives, the present invention claims a primer and probe combination for use in the NovaHT multiplex fluorescence bioanalysis system for multiplex detection of 17 tick-borne pathogens.
[0007] The present invention also aims to provide a kit for multiplex detection of 17 pathogens and a method for multiplex detection of 17 pathogens.
[0008] In a first aspect, the present invention provides a primer and probe combination for multiplex detection of 17 tick-borne pathogens using a NovaHT multiplex fluorescence bioanalysis system, wherein the pathogens include relapsing fever spirochetes, Babesia, Rickettsia, Orientia tsutsugamushi, Rickettsia prowazekii, Rickettsia morozei, Collinsella burnetii, Leptospira, Bartonella, Ehrlichia, Anaplasma, Borrelia burgdorferi, Hantavirus, Seoul virus, tick-borne encephalitis virus, fever with thrombocytopenia syndrome virus, and Xinjiang hemorrhagic fever virus; the primer and probe combination includes an outer primer, an inner primer, and a probe, wherein the 5' end of the downstream primer of the inner primer is labeled with biotin; wherein the nucleotide sequences of the outer primers for the pathogens are sequentially shown in SEQ ID NOs: 1-51 in the sequence table; the nucleotide sequences of the inner primers for the pathogens are sequentially shown in SEQ ID NOs: 54-103 in the sequence table; and the nucleotide sequences of the probes for the pathogens are sequentially shown in SEQ ID NOs: 107-128 in the sequence table.
[0009] According to a preferred embodiment of the present invention, the primer and probe composition also includes an external primer, an internal primer and a probe for an internal reference, the target gene of the internal reference is Globin, the nucleotide sequences of the external primers for the internal reference are sequentially shown in SEQ ID NOs:52-53 in the sequence listing; the nucleotide sequences of the internal primers for the internal reference are sequentially shown in SEQ ID NOs:104-106 in the sequence listing; the nucleotide sequences of the probe for the internal reference are sequentially shown in SEQ ID NO:129 in the sequence listing.
[0010] According to a preferred embodiment of the present invention, the tag sequence coupled to the fluorescent microsphere can specifically and complementary bind to the probe in the primer and probe composition.
[0011] In a second aspect, the present invention provides a kit for multiplex detection of 17 pathogens, comprising the above-mentioned primer and probe combination.
[0012] According to a preferred embodiment of the present invention, the kit for multiplex detection of 17 pathogens also includes a conjugate of streptavidin and phycoerythrin, SA-PE, and a flow cytometer is used for on-machine detection.
[0013] According to a preferred embodiment of the present invention, the kit for multiplex detection of 17 pathogens also includes a negative quality control product.
[0014] Preferably, the negative control is sterile water;
[0015] Further preferably, the sterile water is Nuclease-Free Water;
[0016] In a third aspect, the present invention provides a multiplex detection method for 17 pathogens, comprising the above-mentioned primer and probe combination, wherein the detection steps include two rounds of PCR amplification, hybridization reaction with fluorescent microspheres, and on-machine detection using a flow cytometer.
[0017] According to a preferred embodiment of the present invention, the two-round PCR amplification is a first round of amplification based on the outer primers on the sample to be tested, and a second round of amplification based on the inner primers and the first round of amplification products, and the second round of amplification products obtained in the second round of amplification carry biotin labeled on the inner primers; the hybridization reaction includes first preparing the probes and the corresponding fluorescent microspheres into a liquid chip, and then hybridizing the second round of amplification products with the probes on the liquid chip to form hybridization products.
[0018] According to a preferred embodiment of the present invention, the hybridization reaction further comprises adding a conjugate of streptavidin and phycoerythrin, SA-PE, so that a coupling reaction can be carried out between the biotin labeled on the second round amplification product and the conjugate of streptavidin and phycoerythrin.
[0019] In a fourth aspect, the present invention provides a primer and probe combination, a kit for multiplex detection of 17 pathogens, a method for multiplex detection of 17 pathogens, and use of the same in the preparation of a multiplex detection kit for tick-borne pathogens.
[0020] Beneficial effects of the present invention:
[0021] The present invention adopts NovaHT multiple fluorescence bioanalysis system, and provides a multiple nucleic acid detection method for 17 tick-borne pathogens, wherein the 17 tick-borne pathogens are relapsing fever spirochetes, Babesia, Klebsiella, Orientia tsutsugamushi, Rickettsia prowazekii, Rickettsia morokii, Benacolinella, Leptospira, Bartonella, Ehrlichia neoformans, Anaplasma, Borrelia burgdorferi, Hantavirus, Seoul virus, fever with thrombocytopenia syndrome virus, tick-borne encephalitis virus and Xinjiang hemorrhagic fever virus. At present, most of the detection methods for tick-borne pathogens are single-pathogen detection, and multiple pathogens cannot be detected simultaneously. The 17 tick-borne pathogens of the present invention cover the relevant important pathogens of clinical fever with rash syndrome, and quantitative nucleic acid detection of 19 target genes of 17 pathogens is performed on a sample to be tested simultaneously, which not only saves the sample collection amount (such as the number of blood collection tubes), but also can further save the detection time and the detection cost of multiple projects, improve the detection efficiency, and have a good application prospect.
[0022] The present invention screened 17 tick-borne pathogens, and finally obtained a primer and probe combination of 53 external primers, 53 internal primers and 23 probes for 19 target genes and 1 internal reference gene, which were used together for multiple joint detection of these 17 tick-borne pathogens, involving the detection of 20 target genes and 129 primers and probes corresponding thereto. The present invention adopts the NovaHT multiple fluorescent bioanalysis system, on the one hand, by optimizing specific reaction conditions, using biotin-avidin and fluorescent microspheres for dual labeling, and on the other hand, by continuously optimizing and adjusting the sequences during the design of primer and probe sequences, 1-3 degenerate bases are introduced into many primer and probe sequences. The above optimization not only overcomes the mutual interference between primers or the influence of cross-nonspecific reactions such as dimers, but also the presence of degenerate bases can overcome the uncertainties such as unpredictable evolutionary variations between different strains of pathogens, and can especially cover the detection of different virus strains of 6 target genes of 5 viruses. Moreover, it is able to strike a balance between the detection sensitivity and accuracy of 20 target genes of 17 pathogens. The present invention has accomplished the challenge of maintaining high accuracy while ensuring high sensitivity for 20 detection targets, which is undoubtedly a huge success.
[0023] Traditional PCR amplification of pathogens often uses a pair of primers and only undergoes one round of amplification. The present invention combines the principle of nested PCR on the basis of liquid phase chips, and uses two sets of primers (external primers, internal primers) to perform two rounds of PCR amplification on a pathogen, which not only avoids the false negative results caused by the systematic loss of samples during the sample nucleic acid extraction process, but also increases the detection rate of pathogen detection. In addition, whether it is an external primer or an internal primer, in the primer design optimization process, in addition to using a pair of primers, the primer design of some pathogens also includes adjusting the number of primers, such as a set of primers used to complete a round of PCR amplification of the same target gene, not only there are at least 1 to 3 pairs of symmetrical primer combinations, but also 3 or 5 asymmetric primer combinations. The present invention optimizes the combination of symmetrical or asymmetric primers and combines the use of two sets of primers for two rounds of PCR amplification, while improving the coverage of multiple detection, it also improves the specificity of multiple detection PCR amplification.
[0024] In addition, the NovaHT multiple fluorescence bioanalysis system used in the present invention belongs to a liquid chip. Unlike the traditional solid chip technology, there is no need to spot samples on the chip, but the probe is combined with a microsphere carrier and suspended in a liquid environment to detect the sample. This method has the advantages of simple operation, short time consumption, high throughput and high accuracy, and is suitable for high-throughput rapid detection of a large number of samples. Moreover, the NovaHT multiple fluorescence bioanalysis system of the present invention is based on a flow cytometer for detection. Compared with the traditional Luminex liquid chip multiple detection technology that relies on a flow cytometer with high purchase, maintenance and use costs, it greatly reduces the cost while ensuring the detection performance. Moreover, as a domestic device, the NovaHT flow cytometer can be commercially applied to get rid of the dependence on imported equipment and reagents such as sheath fluid. The present invention uses the NovaHT multiple fluorescence bioanalysis system, and the detection results include data results such as the average value of fluorescence intensity, which are statistically significant, and can be automatically analyzed, which is conducive to the automation of the detection result report.
[0025] The present invention provides a preferred multiplex detection method for 17 tick-borne pathogens, including two rounds of PCR amplification of the nucleic acid sample to be tested, the biotin on the PCR product is combined with SA-PE, the specific probe is combined with the fluorescent microsphere to form a final hybridization product, the classification fluorescence on the fluorescent microsphere is excited by a red laser and the type of the fluorescent microsphere is identified, and the intensity of the fluorescent signal is further increased by exciting phycoerythrin (PE) with a green laser, and finally the median fluorescence intensity value (MFI) of the fluorescent microsphere is used as the judgment standard of the test result, and the difference between the positive and negative values is obvious, and the output of the test result can be digitized and automated. The multiplex detection platform for 17 tick-borne pathogens provided by the present invention includes a multiplex detection kit for 17 tick-borne pathogens and corresponding standard substances, etc., which not only realizes multiplex detection of 17 pathogens, but also has a sensitivity of at least 10 copies / μL, and there is no cross-effect between different pathogens, and the detection specificity is good; after verification of clinical samples and review of third-party detection reagents or detection methods, it can be seen that the multiplex detection method for 17 tick-borne pathogens provided by the present invention is highly reliable. The multiplex detection method of the present invention for 17 tick-borne pathogens realizes the multiplex detection of 19 target genes of 17 pathogens, and compared with the traditional single pathogen nucleic acid detection, it overcomes the limitation that the sensitivity decreases with the increase of the number of pathogens. In addition, the multiplex detection platform of the present invention for 17 tick-borne pathogens is also provided with internal references and standard substances, and the detection operation is simple. After the second round of PCR amplification, the PCR product does not need to be processed, and the hybridization reaction can be directly carried out, which saves the sample usage, the detection reaction steps, and the detection time. In addition, the detection of the present invention does not rely on the traditional flow cytometer, and the detection cost is relatively low. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 The figure is a test result diagram of multiple detection of 21 samples by the present invention; the horizontal axis is the detection target gene, the vertical axis is the median fluorescence intensity value (MFI), the unit is pg / mL, and the dotted line represents the determination baseline of 3×BFI;
[0027] Figure 2 The figure is a test result diagram of 21 samples using a third-party SFTSV real-time fluorescence quantitative detection reagent in the present invention; A is the qPCR test result of SFTSV, and B is the ROX dye internal reference test result of qPCR; wherein the horizontal axis is the detection target gene, and the vertical axis is the CT value;
[0028] Figure 3 This is a sequence comparison result diagram of sequencing verification of the positive result of Rickettsia No. 11 in the multiple detection method of the present invention. DETAILED DESCRIPTION
[0029] The following exemplary embodiments of the present invention are described in detail in conjunction with practical applications. In the following detailed description, for ease of explanation, many specific details are described to provide a comprehensive understanding of the disclosed embodiments. The following examples are only used to illustrate the present invention and should not be considered to limit the scope of the present invention. The experimental methods used in the following examples are conventional methods unless otherwise specified, and the materials, reagents, etc. used, unless otherwise specified, can be obtained from commercial sources. Among them, NovaHT flow array instrument, streptavidin labeled phycoerythrin (SA-PE), probes and fluorescent microspheres are all purchased from Hubei Xinzongke Virus Disease Engineering Technology Co., Ltd., and SFTSV detection kit (qPCR method), RT enzyme Mix and PCR MIX are all purchased from Takara, Japan. However, it is obvious that one or more embodiments can also be implemented without these specific details. If the specific conditions are not specified in the embodiment, they are carried out according to conventional conditions or conditions recommended by the manufacturer.
[0030] The molecular biology experimental methods not specifically described in the following examples were all performed with reference to the specific methods listed in the book Molecular Cloning Experiment Guide (3rd edition) by J. Sambrook, or in accordance with the kits and product instructions.
[0031] The application objects implemented by the present invention only involve biological samples collected from outside the body, which refer to tissues, body fluids or excrement collected from human or animal bodies, such as blood samples (whole blood / serum / plasma) and body fluid samples (urine / feces / cerebrospinal fluid / serous cavity effusion / sperm / prostatic fluid / vaginal secretions / gastric juice / duodenal drainage fluid and bile / sputum) that have been separated from living human or animal bodies. They are not living human or animal bodies, but inanimate biological samples separated from the body; the direct purpose of the detection is not to obtain the diagnosis result of the disease or the health status, but only to conduct laboratory detection or identification of relevant biological information. The results of the detection or identification are generally referred to as negative or positive, and the detection or identification process does not include the step of comparing the detected biological information (such as negative or positive results) with the benchmark data (disease diagnosis), nor does it include the step of directly deriving the diagnosis result of the disease from the detected biological information, and the detection results cannot be directly used for the diagnosis or treatment of the disease. Therefore, the present invention does not belong to the diagnosis method of the disease, and meets the basic requirements of the Patent Law for the patent protection object.
[0032] Example 1. Design of primers and probes
[0033] After a lot of preliminary research and optimization, the target genes and abbreviations of 17 tick-borne pathogens and internal references are shown in Table 1 below.
[0034] Table 1 Detection target genes and their abbreviations of 17 tick-borne pathogens and internal references
[0035] Abbreviation Pathogens (English) Target gene 1 Borrelia recurrentis QUR 2 Babesia microti smallsubunitribosomalRNA 3 Rickettsiaspp. ompA 4 Orientiatsutsugamushi GroEL 5 Rickettsia prowazekii ompB 6 Rickettsia moseri ompB 7 Coxiella burnetii isocitratedehydrogenase 8A Leptospira tP 8B Leptospira Lip32L 9 Bartonella ITS2 10 Ehrlichia groEL 11 Anaplasmosis msp4 12 Borrelia burgdorferi fla 13 Hantavirus (HTNV) RNA-dependent RNA polymerase 14 Seoul Virus (SEOV) RNA-dependent RNA polymerase 15 Tick-borne encephalitis virus (TBEV) Nsp5 16A Severe fever with thrombocytopenia syndrome virus (SFTSV) SegmentS 16B Severe fever with thrombocytopenia syndrome virus (SFTSV) SegmentM 17 Xinjiang hemorrhagic fever virus (CCHFV) SegmentS B Internal reference (B) Globin
[0036] By continuously optimizing the sequence and quantity of primers and probes for 17 tick-borne pathogens, we finally screened out primer and probe combinations designed and optimized based on the sequence conservative regions of 19 target genes and 1 internal reference gene, including 53 external primers, 53 internal primers and 23 probes. The primer and probe combinations were synthesized by Sangon Biotech Co., Ltd. (Shanghai, China), and their specific sequences are shown in SEQ ID NO: 1-129 corresponding to Table 2-Table 4. Among them, the internal reference gene is the housekeeping gene Globin gene of the human body, which has high stability and strong versatility, can monitor the entire detection process and improve the detection accuracy.
[0037] Table 2 Sequence list of external primers
[0038]
[0039] Table 3 Primer sequence list
[0040]
[0041]
[0042] Note: Among the inner primers in Table 3, the downstream primers of the inner primers (abbreviated as R in the primer name) are all labeled with biotin at the 5' end.
[0043] Table 4 Probe sequence list
[0044]
[0045] From Table 2 and Table 4 above, it is obvious that there are 1-3 degenerate bases marked in red in the sequences of multiple primers or probes, the main purpose of which is to improve the sensitivity and coverage of the detection target. The above primer or probe combination is used for multiple detection of 17 tick-borne pathogens by NovaHT multiplex fluorescent bioanalysis system, wherein a tag sequence is coupled to the fluorescent microsphere, and the specific nucleotide sequence of the tag sequence (Table 5) can be complementary to the 5' sequence of the corresponding probe in Table 4.
[0046] Table 5 Tag sequence information table
[0047] Abbreviation Tag sequence name Tag sequence (5'~3') Probe SEQ complementary to the 5' sequence 16A A1 gatttgtattgattgagattaaag SEQ ID NO:127 11 A2 tgattgtagtatgtattgataaag SEQ ID NO:120 1 A3 gattgtaagatttgataaagtgta SEQ ID NO:107 2 A4 gatttgaagattattggtaatgta SEQ ID NO:109 12 A5 gattgattattgtgatttgaattg SEQ ID NO:122 3 A6 gatttgattgtaaaagattgttga SEQ ID NO:110 15 A7 attggtaaattggtaaatgaattg SEQ ID NO:126 B A8 gtaagtaatgaatgtaaaaggatt SEQ ID NO:129 13 A9 gtaagatgttgatatagaagatta SEQ ID NO:123 14 A10 tgtagatttgtatgtatgtatgat SEQ ID NO:124 4 B1 gtaaaaagaaaggtataaaggtaa SEQ ID NO:111 5 B2 gattaaagttgattgaaaagtgaa SEQ ID NO:112 6 B3 gtagattagtttgaagtgaataat SEQ ID NO:113 7 B4 aaaggattaaagtgaagtaattga SEQ ID NO:114 8A B5 atgaattggtatgtatatgaatga SEQ ID NO:115 8B B6 tgaaatgaatgaatgatgaaattg SEQ ID NO:117 9 B7 attgattgtgaatgaaatgaattg SEQ ID NO:118 10 B8 attgaaagatgaaaagatgaaaag SEQ ID NO:119 17 B10 atgatgtaatgaaaagattgtgta SEQ ID NO:128
[0048] Example 2: Establishment of a multiplex detection platform for 17 pathogens
[0049] 2.1 Preparation of standard substances
[0050] The target fragment sequences of the target genes corresponding to the primer and probe combinations obtained by designing, optimizing and screening 17 tick-borne pathogens were commissioned to be synthesized by Sangon Biotech Co., Ltd. (Shanghai, China) and cloned into the pUC57 vector to obtain recombinant plasmids. After the plasmids were extracted, the plasmid concentration was measured by a spectrophotometer, and the plasmid concentration was converted into the copy number using the Avogadro constant-copy number calculation formula: copy number (copies / μL) = 6.02×10 23 × plasmid concentration (ng / μL×10 -9 ) / (DNA length × 660), and use sterile water to dilute the plasmid to 10 5 , 10 4 , 10 3 , 10 2 , 10 1 , 10 0.5 , 1 copy / μL, as a standard substance for a series of concentrations, stored at -20℃ for later use.
[0051] 2.2. Liquid phase chip preparation and nucleic acid amplification
[0052] Preparation of liquid chip: Take the fluorescent probes synthesized according to Table 4 and mix them with fluorescent microspheres coupled with complementary sequences for hybridization coupling. The mixture of 23 fluorescent probes and the corresponding fluorescent microspheres are mixed in a ratio of 1:1 to prepare a liquid chip, which is stored at 4°C for use.
[0053] Nucleic acid amplification reaction: using the outer primers and inner primers in Table 2 and Table 3 respectively, two rounds of PCR amplification are performed successively, and the amplified product obtained by the second round of PCR amplification is hybridized with the prepared liquid chip, and the obtained hybridization product is scanned by a flow array instrument, and the optical signal is collected and analyzed according to the scanning, thereby completing the detection of the sample and the output of the digital detection result. The specific operation of nucleic acid amplification is as follows:
[0054] First round of amplification: Prepare the first round of amplification reaction system according to the proportions shown in Table 6, do not add the amplification template first, flick to mix, then centrifuge instantly, and quickly transfer to the refrigeration well plate; take out the amplification template to be tested (sample / quality control product to be tested), flick to mix, then centrifuge instantly, take 5μL from each and add it to the corresponding PCR reaction tube, flick to mix, then centrifuge instantly; place the PCR reaction tube in the PCR instrument for the first round of amplification, i.e., RT-PCR reaction; the first round of PCR program is: 42℃20min; 95℃ pre-denaturation 1min; 95℃10sec, 55℃1min, 72℃10sec, 15 cycles; finally 72℃ extension 5min. The first round of amplification products obtained after the first round of PCR reaction are stored at 4℃.
[0055] Table 6 First round amplification reaction system
[0056]
[0057] Second round of amplification: Take a new PCR reaction tube, prepare and add the second round of amplification PCR reaction system according to the proportion shown in Table 7, do not add the amplification template (first round amplification product) first, flick to mix, then centrifuge instantly, and quickly transfer to a refrigeration well plate; take 2.5 μL of the first round amplification product and add it to the PCR reaction tube corresponding to the second round mark, flick to mix, then centrifuge instantly; and place the PCR reaction tube in the PCR instrument for the second round of amplification; the second round of PCR program is: 95℃ pre-denaturation for 1 min; 95℃10sec, 55℃1min, 72℃10sec, 35 cycles; finally 72℃ extension for 5 min.
[0058] Table 7 Second round amplification reaction system
[0059]
[0060] The second-round amplification products obtained after the second-round PCR reaction can be placed at 4°C for subsequent hybridization reactions, or can be frozen at -20°C for a short period of time, or frozen at -80°C for a long period of time. PCR amplification reaction: pre-denaturation at 98°C for 5 min, 98°C for 30 s, 58°C for 30 s, 72°C for 1 min, 40 cycles, and finally extension at 72°C for 5 min.
[0061] 2.3 Hybridization reaction
[0062] Take out the prepared liquid chip (containing the mixed solution of fluorescent probe and fluorescent microspheres), vortex and mix thoroughly, and then centrifuge instantly. Prepare the hybridization reaction system according to the proportions shown in Table 8, and add the configured hybridization system to each reaction well of the PCR eight-tube. Take 2.5μL of the second round of amplification product and add it to the corresponding reaction well. Place the PCR eight-tube in the PCR instrument for hybridization reaction. The hybridization reaction procedure is: pre-denaturation at 95℃ for 2min, 16℃ for 1min, and 60℃ for 10min. Then add 5μL SA-PE (a conjugate of streptavidin and phycoerythrin) to each reaction well and incubate at 37℃ for 30min. After incubation, quickly place the PCR eight-tube in the NovaHT sample tray, the temperature is preset to 37℃, and the machine is tested and the results are determined. During the NovaHT on-machine detection process, the specific fluorescent microsphere number is identified by stimulating the red fluorescence on the fluorescent microsphere, and the fluorescence intensity of the hybridization product is read by stimulating the phycoerythrin coupled to the surface of the fluorescent microsphere. The detection output data is the median fluorescence intensity value (MFI) of the fluorescent microsphere group corresponding to each fluorescent microsphere number. Among them, since the coupling system of streptavidin-labeled phycoerythrin (SA-PE) is a powerful non-covalent binding system, it can significantly enhance the fluorescence signal intensity of the fluorescent microspheres and improve the sensitivity and accuracy of the detection. That is, the present invention combines the flow dot matrix instrument (NovaHT) with the SA-PE system, and amplifies the detection signal of NovaHT by SA-PE, which further improves the sensitivity of NovaHT detection.
[0063] Table 8 Hybridization reaction system
[0064]
[0065] Result determination: Sterile water (Nuclease-Free Water) is used as the sample to be tested as a negative control, and the test result value of the negative control is used as the background, recorded as BFI. For the test results of different reaction systems, the data output by the instrument is the median fluorescence intensity value (MFI) of each fluorescent microsphere in the corresponding reaction system. The criterion for determining a positive test result is: when the MFI value of the sample to be tested is greater than and / or equal to three times the test result value (BFI) of the negative control of this reaction system, it is judged to be positive (+); otherwise it is negative (-), that is, MFI(+)≥3×BFI, MFI(-)<3×BFI.
[0066] Among them, regarding the above hybridization reaction, the hybridization temperature and hybridization time in the hybridization reaction program are the optimal reaction conditions obtained through specific experimental screening, such as using standard substances (10 2 After completing two rounds of nucleic acid amplification under the same conditions, the hybridization temperature conditions were optimized and verified. In particular, the hybridization temperature of the last step of the hybridization reaction procedure was verified to be 50°C, 55°C, and 60°C, based on the screening of the optimal hybridization time of 10 minutes. The hybridization temperature was verified successively, including three temperature gradients of 50°C, 55°C, and 60°C, that is, the specific hybridization reaction procedure was: 95°C pre-denaturation for 2 minutes, 16°C for 1 minute, 50°C / 55°C / 60°C for 10 minutes; after adding 5μL SA-PE, incubate at 37°C for 30 minutes; after incubation, place in the NovaHT sample tray for on-machine detection and result determination. The detection results of different hybridization temperatures are shown in Tables 9 to 11.
[0067] Table 9 Hybridization reaction conditions (60°C hybridization 10 min)
[0068]
[0069] Table 10 Hybridization reaction conditions (55°C hybridization for 10 min)
[0070]
[0071] Table 11 Hybridization reaction conditions (50°C hybridization 10 min)
[0072]
[0073] By comparing the results in Tables 9 to 11, it can be seen that the final concentration of the samples to be tested is 1×10 2When the hybridization temperature was 60℃, the positive and negative values were significantly different, and there was no false positive value; when the hybridization temperature was 55℃, the fluorescence value of Seoul virus and other detection targets was much higher than three times the BFI value of the negative control test result; and when the hybridization temperature was 50℃, the fluorescence value of more detection targets such as Anaplasma and Hantavirus was much higher than three times the BFI value of the negative control test result. Therefore, the selection of 60℃ as the hybridization temperature and the reaction condition for multiple detection of 17 tick-borne pathogens is more conducive to the balance between sensitivity and accuracy for all detection targets, and the final concentration of the standard substances is 1×10 2 When hybridized at 60℃ for 10min, not only the positive and negative values of different detection targets are obviously different, there is no detection grayscale, and the positive detection fluorescence values of different detection targets are relatively more balanced. Therefore, hybridization at 60℃ for 10min is relatively more advantageous. Other amplification conditions were also optimized and screened for the best reaction conditions. The specific screening process and experimental data are too large (including data from the early primer design, screening, optimization and adjustment processes), so they will not be listed one by one.
[0074] Example 3: Performance evaluation of a multiplex detection platform for 17 pathogens
[0075] 3.1 Specificity and sensitivity
[0076] Multiple detections were performed according to the preferred reaction conditions of the above two rounds of nucleic acid amplification reactions and hybridization reactions. The optimal reaction system screened and verified above (for example, a hybridization temperature of 60° C. and a hybridization time of 10 min) was used for two rounds of amplification, hybridization and detection to compare whether there was a cross-influence between the median fluorescence intensity values (MFI) detected for each pathogen and the specific sensitivity of the detection values. The results are shown in Table 5 below.
[0077] The samples to be tested are selected from standard substances with 7 concentration gradients. E5~E0 represent the abbreviations of the 7 concentration gradients of the standard substances, and the concentrations are: 10 5 copies / μL, 10 4 copies / μL, 10 3 copies / μL, 10 2 copies / μL, 10 1 =10 copies / μL, 10 0.5 copies / μL, 10 0 =1 copies / μL, and the median fluorescence intensity (MFI) values of the standard substances at 7 different concentrations were compared. The results are shown in Table 12 below.
[0078] First, the test results in Table 12 show that as the concentration of the standard substance increases, for example, from 10 2The copies / μL increased to 10 5 copies / μL, the corresponding median fluorescence intensity value (MFI) was judged as positive, wherein, although the median fluorescence intensity value (MFI) increased slightly with the increase of concentration, the median fluorescence intensity value (MFI) was not necessarily related to the concentration value of the standard substance, and there was no cross-influence between different detection objects, that is, the positive result of multiple detection was specific; on the other hand, among the 17 tick-borne pathogens, leptospira and fever with thrombocytopenia syndrome virus screened 2 target genes respectively, and in the detection verification results of different target genes of the same pathogen, there was no non-specific result of positive cross-detection between different target genes. Therefore, the multiple detection platform of the present invention for 19 target genes of 17 tick-borne pathogens has good specificity.
[0079] Table 12 Specificity and sensitivity
[0080]
[0081]
[0082]
[0083]
[0084]
[0085] Secondly, the test results in Table 12 verify that the standard substance is 5 copies / μL up to 10 0 The multiple detection results of 7 concentration gradients were as follows: 2 When the detection rate was 10 copies / μL, the multiple detection of 19 target genes of 17 tick-borne pathogens could all be judged as positive, that is, the detection sensitivity of 19 target genes could reach at least 10 2 It can be further seen that the detection sensitivity of the two target genes corresponding to Babesia and Coxiella burnetii is only 10 copies / μL, and the detection sensitivity of the other 17 target genes is relatively higher. Among them, the detection sensitivity of the seven target genes corresponding to the six pathogens of Rickettsia, Leptospira, Bartonella, New Ehrlichia, Hantavirus, Seoul virus, fever with thrombocytopenia syndrome virus-S fragment, and Xinjiang hemorrhagic fever virus can reach 10 0.5The detection sensitivity of the eight target genes corresponding to the eight pathogens, including relapsing fever spirochetes, orientia tsutsugamushi, Rickettsia prowazekii, Rickettsia morozekii, Anaplasma, Borrelia burgdorferi, tick-borne encephalitis virus, and fever with thrombocytopenia syndrome virus-M fragment, can reach 10 0 =1 copies / μL. It can be seen that the lowest detection limit (sensitivity) of the present invention for 19 target genes of 17 pathogens can reach 10 copies / μL, and the difference between positive and negative is obvious. Compared with the traditional multiplex PCR detection method, the sensitivity of the present invention has obvious advantages.
[0086] 3.2 Clinical samples
[0087] According to the preferred reaction conditions of the above two rounds of nucleic acid and hybridization reactions of the present invention (such as a hybridization temperature of 60° C. and a hybridization time of 10 min), multiple detection was performed on 21 clinical nucleic acid samples derived from suspected symptoms related to tick-borne pathogen infection. The preferred detection method of the present invention for 17 tick-borne pathogens was used to perform detection tests. The multiple detection results of the 21 samples are as follows: Figure 1 As shown in the figure, according to the median fluorescence intensity (MFI) of the test results: 3 samples were positive for fever with thrombocytopenia syndrome (SFTSV), and 1 sample was positive for Rickettsia. The 21 samples were re-tested using a third-party reagent SFTSV detection kit (qPCR method), and the test results are as follows Figure 2 As shown in the figure, 3 samples were also positive for fever with thrombocytopenia syndrome (SFTSV). One sample was positive for Rickettsia, and the positive sample was sequenced using the Sager sequencing method. The sequencing results are shown in the figure. Figure 3 As shown, it is further verified that the sequence of sample No. 11 is consistent with the sequence of Rickettsia. Therefore, the present invention establishes a multiplex detection method for 17 tick-borne pathogens, and the specificity and feasibility of the multiplex detection method are verified by clinical samples, and the detection results are 100% consistent with the third-party reagents or detection methods of a single detection object, that is, the multiplex detection method of the present invention for 17 tick-borne pathogens realizes multiplex detection with high reliability.
[0088] The present invention provides a multiplex detection method for 17 tick-borne pathogens. According to the overall concept of the present invention, a set of primer and probe compositions are successfully designed and optimized and screened. The primer and probe compositions target 19 target genes of the 17 tick-borne pathogens and a conserved sequence of an internal reference gene, and include 53 preferred external primers, 53 internal primers and 23 probes. The internal reference is the Globin gene, which has high stability and strong versatility, and can monitor the entire detection process including the nucleic acid extraction step, thereby further improving the detection accuracy. Based on the primer and probe combination, the hybridization temperature and hybridization time are also optimized and screened, such as hybridization at 60°C for 10 minutes, which can not only effectively balance the detection efficiency of 19 target genes of 17 tick-borne pathogens, but also have obvious positive and negative differences. Finally, the present invention provides a preferred multiplex detection method for 17 tick-borne pathogens, including two rounds of PCR amplification of the nucleic acid sample to be tested, the biotin on the PCR product is combined with SA-PE, and the specific probe is combined with the fluorescent microsphere to form a final hybridization product, the classification fluorescence on the fluorescent microsphere is excited by red laser and the type of fluorescent microsphere is identified, and the phycoerythrin (PE) is excited by green laser to further increase the intensity of the fluorescent signal, and finally the median fluorescence intensity value (MFI) of the fluorescent microsphere is used as the judgment standard of the detection result, and the output of the detection result can be digitized and automated. The multiplex detection platform for 17 tick-borne pathogens provided by the present invention includes multiplex detection kits and corresponding standard substances for 17 tick-borne pathogens, which not only realizes multiplex detection of 17 pathogens with a sensitivity of 10 copies / μL, but also has no cross-influence between different pathogens and good detection specificity. After verification of clinical samples and review of third-party detection reagents or detection methods, it can be seen that the multiplex detection method for 17 tick-borne pathogens provided by the present invention has high reliability.
[0089] The specific embodiments of the present invention have been described in detail so that those skilled in the art will be easily understood. However, according to all the descriptions disclosed, different modifications or replacements can be made to those details, and these changes are within the scope of protection of the present invention. The full scope of the present invention is given by the attached claims and any equivalents thereof.
Claims
1. A primer and probe combination for multiplex detection of 17 tick-borne pathogens using the NovaHT multiplex fluorescent bioanalysis system, including relapsing fever spirochetes, Babesia, Rickettsia, Orientia tsutsugamushi, Rickettsia prowazekii, Rickettsia morozei, Collinsella burnetii, Leptospira, Bartonella, Ehrlichia neoformans, Anaplasma, Borrelia burgdorferi, Hantavirus, Seoul virus, tick-borne encephalitis virus, fever with thrombocytopenia syndrome virus, and Xinjiang hemorrhagic fever virus; The primer and probe combination comprises an outer primer, an inner primer and a probe, and the 5' end of the downstream primer of the inner primer is labeled with biotin; in, The nucleotide sequences of the external primers for the pathogen are shown in SEQ ID NOs: 1-51 in the sequence list; the nucleotide sequences of the internal primers for the pathogen are shown in SEQ ID NOs: 54-103 in the sequence list; the nucleotide sequences of the probes for the pathogen are shown in SEQ ID NOs: 107-128 in the sequence list.
2. The primer and probe combination according to claim 1, Features: It also includes external primers, internal primers and probes for internal references, the target gene of the internal reference is Globin, the nucleotide sequences of the external primers for the internal reference are shown in SEQ ID NOs:52-53 in the sequence list; the nucleotide sequences of the internal primers for the internal reference are shown in SEQ ID NOs:104-106 in the sequence list; the nucleotide sequences of the probes for the internal reference are shown in SEQ ID NO:129 in the sequence list.
3. The primer and probe combination according to claim 1, Features: The tag sequence coupled to the fluorescent microsphere can specifically and complementary bind to the probe.
4. A kit for multiplex detection of 17 pathogens, Features: The invention comprises the primer and probe composition according to any one of claims 1 to 3.
5. The kit for multiplex detection of 17 pathogens according to claim 4, Features: It also includes a conjugate of streptavidin and phycoerythrin, SA-PE, and uses a flow cytometer for on-machine detection.
6. The kit for multiplex detection of 17 pathogens according to claim 4, Features: Negative controls are also included.
7. A multiplex detection method for 17 pathogens, Features: The method comprises the primer and probe combination according to any one of claims 1 to 3, wherein the detection step comprises two rounds of PCR amplification, hybridization reaction with fluorescent microspheres, and on-machine detection using a flow cytometer.
8. The multiplex detection method for 17 pathogens according to claim 7, Features: The two-round PCR amplification is to perform a first round of amplification on the sample to be tested based on the outer primers, and to perform a second round of amplification based on the inner primers and the first round of amplification products, and the second round of amplification products obtained in the second round of amplification carry the biotin labeled on the inner primers; The hybridization reaction includes first preparing the probe and the corresponding fluorescent microspheres into a liquid chip, and then hybridizing the second round amplification product with the probe on the liquid chip to form a hybridization product.
9. The multiplex detection method for 17 pathogens according to claim 8, Features: The hybridization reaction further comprises adding a conjugate of streptavidin and phycoerythrin, SA-PE, so that a conjugate reaction can be carried out between the biotin labeled on the second round amplification product and the conjugate of streptavidin and phycoerythrin.
10. Use of the primer and probe combination described in any one of claims 1-3, the kit for multiplex detection of 17 pathogens described in any one of claims 4-6, and the method for multiplex detection of 17 pathogens described in any one of claims 7-9 in the preparation of a multiplex detection kit for tick-borne pathogens.
Citation Information
Cited By
Rapid detection method for respiratory system infection pathogens based on multiple PCR (Polymerase Chain Reaction)
CN121350717A
High-flux multiple real-time fluorescent quantitative detection method applicable to 25 tick-borne pathogens and application
CN121380301A
A high-throughput multiplex real-time fluorescent quantitative detection method suitable for 25 tick-borne pathogens and application
CN121380301B
Primer probe combination, kit and detection method for simultaneously detecting nucleic acids of four tick-borne pathogens based on liquid chip
CN122484353A
